£6.5M
The financing values the synthetic biology business at £30.5m post-money.
OG
Oxford Genetics
Oxford Genetics develops advanced technologies for drug and gene therapy.
Oxford, UK
£6.5MTotal raised
Oxford Genetics provides advanced technologies and techniques for drug and gene therapy development. The company operates in the synthetic biology market, offering solutions for gene discovery, antibody therapy, and CRISPR gene editing.
Categories
Founders
Ryan Cawood
Founder and CEO
Ryan brings founding and scientific leadership experience from Oxford Genetics, OXGENE, and WuXi Advanced Therapies.